Skip to content
healthcare.dev

NEUPOGEN

NDC 55513-209, Filgrastim, injection, solution, from Amgen, Inc.

Product NDC
55513-209
Status
Listed
Labeler
Amgen, Inc
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA103353
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55513-209 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FILGRASTIM480 ug/.8mL

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
55513-209-105551302091010 SYRINGE in 1 BOX (55513-209-10) / .8 mL in 1 SYRINGE (55513-209-01)
55513-209-205551302092010 SYRINGE in 1 BOX (55513-209-20) / .8 mL in 1 SYRINGE (55513-209-01)
55513-209-91555130209911 SYRINGE in 1 BOX (55513-209-91) / .8 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/97cc73cc-b5b7-458a-a933-77b00523e193
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55513-209

Use it

Look up 55513-209 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55513-209 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55513-209. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.